<DOC>
	<DOCNO>NCT00088608</DOCNO>
	<brief_summary>The study treatment period 15 day length include patient pituitary Cushing 's disease candidate surgical intervention well patient recurrent Cushing 's post operatively .</brief_summary>
	<brief_title>A Study Assess SOM230 Patients With Pituitary Cushing 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Cushing Syndrome</mesh_term>
	<mesh_term>Pituitary ACTH Hypersecretion</mesh_term>
	<mesh_term>ACTH-Secreting Pituitary Adenoma</mesh_term>
	<criteria>Patients pituitary Cushing 's disease within two month prior study entry Patients write informed consent participate study obtain Female patient child bear potential undergone clinically document total hysterectomy and/or ovariectomy , tubal ligation must agree use barrier contraception throughout course study , one month study end Female patient pregnant lactating Patients previously treat certain medication may require without certain medication prior enter study Poorly control diabetes mellitus indicate presence ketoacidosis HgbA1C &gt; 10 Patients congestive heart failure , unstable angina , cardiac arrhythmia history acute MI le one year prior study entry clinically significant impairment cardiovascular function ( e.g . blood pressure 190/100mmHg great ) Patients chronic liver disease Patients clot disorder abnormal blood count History immunocompromise , include positive HIV test result Patients active gall bladder disease Patients participate clinical investigation investigational drug within 1 month prior dose Patients active malignant disease ( exception basal cell carcinoma carcinoma situ cervix )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>